Latest Roche News & Updates

See the latest news and media coverage for Roche. We track all announcements, press releases, and industry mentions in real time, all in one place.

Roche

Pharmaceuticals and diagnostics company

roche.com

Headquarters: Switzerland 🇨🇭 , Switzerland
Company type: Public company
Number of employees: 100,000+
Industry: Pharmaceuticals

Last updated October 23

Latest news about Roche

In short: Roche posted higher sales and advanced oncology, MS, and diagnostics pipelines while securing new approvals.

Company announcements

October 23 Roche

Roche presents positive interim phase III data for sefaxersen in IgAN

The investigational drug achieved a significant 43.1% reduction in proteinuria versus placebo at 37 weeks and was well tolerated.

October 22 Roche

Roche reports YTD sales growth

Group sales rose 6%, driven by pharmaceuticals. The company confirms 2026 guidance for mid-single digit sales growth and high single-digit core EPS growth.

October 10 Roche

Roche presents new vamikibart Phase III data for UME

Data from MEERKAT and SANDCAT studies show sustained vision improvements. The FDA has accepted the BLA with a decision expected by July 2027.

October 9 Roche

Roche gains FDA approval for Tecentriq in stage III colon cancer

This first adjuvant immunotherapy reduces recurrence risk by 50% based on the ATOMIC study results published in NEJM.

Media coverage

October 23 cash

Roche achieves progress with kidney drug Sefaxersen

Roche has achieved positive results in an interim analysis of a Phase III study with the investigational drug Sefaxersen in patients with IgA nephropathy (IgAN).

October 22 FierceBiotech

Roche pays Zymeworks $55M for trispecific challenger to Amgen’s Imdelltra

Roche is paying Zymeworks $55 million upfront for ZW209, bagging global rights to a trispecific designed to improve on the ...

October 22 Bloomberg

Roche Sales Beat Estimates on Strong Xolair Demand

Revenue grew 8% to 16.1 billion Swiss francs, exceeding forecasts as older blockbuster drug Xolair drove performance.

October 22 MSN

Roche's 9M 2026 sales rise on strong drug demand, pipeline advances

Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 46.5 billion in the first nine months of 2026, up 1% year over year...

Never miss news about Roche

Track Roche and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Roche competitors & trending companies

Browse news for competitors to Roche and other trending companies.